FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793493509> ?p ?o ?g. }

• W2793493509 abstract "Background: We previously demonstrated that the majority of women ≤45 years experienced chemotherapy-induced ovarian failure (CIOF) after CT for EBC. Age, CT regimen, duration and dose-density influenced the rate of CIOF. The regain of premenopausal Follicle-Stimulating Hormone (FSH) and Estradiol (E2) levels after chemotherapy is not equivalent to fertility restoration. The Anti-Muellerian Hormone (AMH) assessment seems to be more accurate than other hormones in predicting the ovarian reserve. FSH, E2 and AMH have been prospectively assessed in young patients receiving (neo)adjuvant CT. Methods: 740 patients (pts) aged ≤45yrs treated with anthracycline or taxane-based CT for EBC from 4 German neoadjuvant/adjuvant trials were included. Blood samples were collected at baseline before CT (N=740), end of treatment (EOT n=740), 6 (n=177), 12 (n=113), 18 (n=69), 24 (n=47) months (m) after EOT. Only the full set of samples of a given patient was included. FSH, E2 and AMH were centrally assessed. Postmenopausal hormone levels of FSH and E2 according to the central laboratory were defined as FSH>12.4IU/l and E2 Results: Median age was 40yrs (range 21-45); 57.2% had BMI 18.5- Conclusion: Nearly 70% of women regain premenopausal hormone levels of FSH and E2 within 2 years after end of CT. Despite that, only less than one third maintain their fertility potential as predicted by AMH. AMH is a very sensitive marker for the prediction of fertility function after CT for EBC. Citation Format: Furlanetto J, Thode C, Huober J, Denkert C, Bassy M, Hanusch C, Jackisch C, Kummel S, Schneeweiss A, Untch M, Fasching PA, Karn T, Marme F, van Mackelenbergh M, Muller V, Schem C, von Minckwitz G, Strik D, Nekljudova V, Loibl S. Changes in hormone levels (E2, FSH, AMH) and fertility of young women treated with neoadjuvant chemotherapy (CT) for early breast cancer (EBC) [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr PD7-09." @default.
• W2793493509 created "2018-03-29" @default.
• W2793493509 creator A5006857767 @default.
• W2793493509 creator A5008563937 @default.
• W2793493509 creator A5011764682 @default.
• W2793493509 creator A5014883814 @default.
• W2793493509 creator A5023886029 @default.
• W2793493509 creator A5024589782 @default.
• W2793493509 creator A5026869170 @default.
• W2793493509 creator A5032626301 @default.
• W2793493509 creator A5033698551 @default.
• W2793493509 creator A5052775627 @default.
• W2793493509 creator A5057181684 @default.
• W2793493509 creator A5067146231 @default.
• W2793493509 creator A5069170386 @default.
• W2793493509 creator A5077307794 @default.
• W2793493509 creator A5077423132 @default.
• W2793493509 creator A5079978147 @default.
• W2793493509 creator A5080084748 @default.
• W2793493509 creator A5087559224 @default.
• W2793493509 creator A5089392438 @default.
• W2793493509 creator A5091848376 @default.
• W2793493509 date "2018-02-14" @default.
• W2793493509 modified "2023-09-27" @default.
• W2793493509 title "Abstract PD7-09: Changes in hormone levels (E2, FSH, AMH) and fertility of young women treated with neoadjuvant chemotherapy (CT) for early breast cancer (EBC)" @default.
• W2793493509 doi "https://doi.org/10.1158/1538-7445.sabcs17-pd7-09" @default.
• W2793493509 hasPublicationYear "2018" @default.
• W2793493509 type Work @default.
• W2793493509 sameAs 2793493509 @default.
• W2793493509 citedByCount "1" @default.
• W2793493509 countsByYear W27934935092019 @default.
• W2793493509 crossrefType "proceedings-article" @default.
• W2793493509 hasAuthorship W2793493509A5006857767 @default.
• W2793493509 hasAuthorship W2793493509A5008563937 @default.
• W2793493509 hasAuthorship W2793493509A5011764682 @default.
• W2793493509 hasAuthorship W2793493509A5014883814 @default.
• W2793493509 hasAuthorship W2793493509A5023886029 @default.
• W2793493509 hasAuthorship W2793493509A5024589782 @default.
• W2793493509 hasAuthorship W2793493509A5026869170 @default.
• W2793493509 hasAuthorship W2793493509A5032626301 @default.
• W2793493509 hasAuthorship W2793493509A5033698551 @default.
• W2793493509 hasAuthorship W2793493509A5052775627 @default.
• W2793493509 hasAuthorship W2793493509A5057181684 @default.
• W2793493509 hasAuthorship W2793493509A5067146231 @default.
• W2793493509 hasAuthorship W2793493509A5069170386 @default.
• W2793493509 hasAuthorship W2793493509A5077307794 @default.
• W2793493509 hasAuthorship W2793493509A5077423132 @default.
• W2793493509 hasAuthorship W2793493509A5079978147 @default.
• W2793493509 hasAuthorship W2793493509A5080084748 @default.
• W2793493509 hasAuthorship W2793493509A5087559224 @default.
• W2793493509 hasAuthorship W2793493509A5089392438 @default.
• W2793493509 hasAuthorship W2793493509A5091848376 @default.
• W2793493509 hasConcept C121608353 @default.
• W2793493509 hasConcept C126322002 @default.
• W2793493509 hasConcept C126894567 @default.
• W2793493509 hasConcept C143998085 @default.
• W2793493509 hasConcept C2776600139 @default.
• W2793493509 hasConcept C2776694085 @default.
• W2793493509 hasConcept C2776802502 @default.
• W2793493509 hasConcept C2777511904 @default.
• W2793493509 hasConcept C2777688143 @default.
• W2793493509 hasConcept C2777904497 @default.
• W2793493509 hasConcept C2778575703 @default.
• W2793493509 hasConcept C2778780466 @default.
• W2793493509 hasConcept C2779234561 @default.
• W2793493509 hasConcept C2779279165 @default.
• W2793493509 hasConcept C2781413609 @default.
• W2793493509 hasConcept C2908647359 @default.
• W2793493509 hasConcept C29456083 @default.
• W2793493509 hasConcept C518429986 @default.
• W2793493509 hasConcept C530470458 @default.
• W2793493509 hasConcept C54355233 @default.
• W2793493509 hasConcept C71315377 @default.
• W2793493509 hasConcept C71924100 @default.
• W2793493509 hasConcept C86803240 @default.
• W2793493509 hasConcept C99454951 @default.
• W2793493509 hasConceptScore W2793493509C121608353 @default.
• W2793493509 hasConceptScore W2793493509C126322002 @default.
• W2793493509 hasConceptScore W2793493509C126894567 @default.
• W2793493509 hasConceptScore W2793493509C143998085 @default.
• W2793493509 hasConceptScore W2793493509C2776600139 @default.
• W2793493509 hasConceptScore W2793493509C2776694085 @default.
• W2793493509 hasConceptScore W2793493509C2776802502 @default.
• W2793493509 hasConceptScore W2793493509C2777511904 @default.
• W2793493509 hasConceptScore W2793493509C2777688143 @default.
• W2793493509 hasConceptScore W2793493509C2777904497 @default.
• W2793493509 hasConceptScore W2793493509C2778575703 @default.
• W2793493509 hasConceptScore W2793493509C2778780466 @default.
• W2793493509 hasConceptScore W2793493509C2779234561 @default.
• W2793493509 hasConceptScore W2793493509C2779279165 @default.
• W2793493509 hasConceptScore W2793493509C2781413609 @default.
• W2793493509 hasConceptScore W2793493509C2908647359 @default.
• W2793493509 hasConceptScore W2793493509C29456083 @default.
• W2793493509 hasConceptScore W2793493509C518429986 @default.
• W2793493509 hasConceptScore W2793493509C530470458 @default.
• W2793493509 hasConceptScore W2793493509C54355233 @default.
• W2793493509 hasConceptScore W2793493509C71315377 @default.
• W2793493509 hasConceptScore W2793493509C71924100 @default.
• W2793493509 hasConceptScore W2793493509C86803240 @default.
• W2793493509 hasConceptScore W2793493509C99454951 @default.

• next